Search Results - "Guastamacchia, E."

Refine Results
  1. 1

    Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects by Lisco, G., De Tullio, A., Jirillo, E., Giagulli, V. A., De Pergola, G., Guastamacchia, E., Triggiani, V.

    Published in Journal of endocrinological investigation (01-09-2021)
    “…Background Thyroid dysfunction has been observed in patients with COVID-19, and endocrinologists are requested to understand this clinical issue…”
    Get full text
    Journal Article
  2. 2

    Molecular mechanisms involved in the control of neurohypophyseal hormones secretion by Iovino, M, Guastamacchia, E, Giagulli, V A, Licchelli, B, Iovino, E, Triggiani, V

    Published in Current pharmaceutical design (01-01-2014)
    “…The regulation of neurohypophyseal peptides secretion reflects the convergence of a large number of afferent neural pathways on vasopressinergic and…”
    Get more information
    Journal Article
  3. 3

    Platelet number is positively and independently associated with glycated hemoglobin in non-diabetic overweight and obese subjects by De Pergola, G., Giagulli, V.A., Guastamacchia, E., Bartolomeo, N., Tatoli, R., Lampignano, L., Silvestris, F., Triggiani, V.

    “…A significant increase in platelet count may be a risk factor for atherosclerotic cardiovascular disease. This study investigates the association between…”
    Get full text
    Journal Article
  4. 4

    Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism by Giagulli, V. A., Carbone, M. D., Ramunni, M. I., Licchelli, B., De Pergola, G., Sabbà, C., Guastamacchia, E., Triggiani, V.

    Published in Andrology (Oxford) (01-11-2015)
    “…Summary The aim of this retrospective observational study was to evaluate whether adding liraglutide to lifestyle changes, metformin (Met) and testosterone…”
    Get full text
    Journal Article
  5. 5

    Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients by Iacoviello, M, Guida, P, Guastamacchia, E, Triggiani, V, Forleo, C, Catanzaro, R, Cicala, M, Basile, M, Sorrentino, S, Favale, S

    Published in Current pharmaceutical design (01-09-2008)
    “…It has been suggested that low thyroid hormones levels may be associated with increased mortality in patients with cardiovascular disease. To evaluate the…”
    Get more information
    Journal Article
  6. 6

    Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations by Giagulli, V A, Triggiani, V, Corona, G, Carbone, D, Licchelli, B, Tafaro, E, Resta, F, Sabbà, C, Maggi, M, Guastamacchia, E

    Published in Current pharmaceutical design (01-05-2011)
    “…Until the 2000s Testosterone (T) Replacement Therapy (TRT) wasn't very satisfactory for male hypogonadic patients because the available T formulations weren't…”
    Get more information
    Journal Article
  7. 7

    Managing erectile dysfunction in heart failure by Giagulli, V A, Moghetti, P, Kaufman, J M, Guastamacchia, E, Iacoviello, M, Triggiani, V

    “…Nowadays, erectile dysfunction (ED) is considered an increasingly important clinical condition in men with heart failure (HF) which may influence the…”
    Get more information
    Journal Article
  8. 8

    Subclinical hypothyroidism and cognitive dysfunction in the elderly by Resta, F, Triggiani, V, Barile, G, Benigno, M, Suppressa, P, Giagulli, V A, Guastamacchia, E, Sabbà, C

    “…While overt hypothyroidism is associated with reversible dementia in the elderly, the relationship of subclinical hypothyroidism with cognition remains a…”
    Get more information
    Journal Article
  9. 9

    Could androgen receptor gene CAG tract polymorphism affect spermatogenesis in men with idiopathic infertility? by Giagulli, V. A., Carbone, M. D., De Pergola, G., Guastamacchia, E., Resta, F., Licchelli, B., Sabbà, C., Triggiani, V.

    “…Purpose This study examined whether the AR-CAG repeat length might affect clinical characteristics (testis volume) seminal parameters (sperm count and its…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis by Lenato, G M, Suppressa, P, Giordano, P, Guanti, G, Guastamacchia, E, Triggiani, V, Amati, L, Resta, F, Covelli, V, Jirillo, E, Sabbà, C

    Published in Current pharmaceutical design (01-12-2007)
    “…Hereditary Haemorrhagic Telangiectasia (HHT) or Rendu-Osler-Weber syndrome is an autosomal dominant disease characterized by local angiodysplasia affecting…”
    Get more information
    Journal Article
  14. 14

    Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia by Jirillo, E, Amati, L, Suppressa, P, Cirimele, D, Guastamacchia, E, Covelli, V, Tafaro, E, Sabbà, C

    Published in Current pharmaceutical design (01-04-2006)
    “…Hereditary hemorrhagic telangiectasia (HHT) is characterized by vessel alterations such as dilatation of postcapillary venules and arterio-venous…”
    Get more information
    Journal Article
  15. 15

    Modifications of the immune responsiveness in patients with autoimmune thyroiditis: evidence for a systemic immune alteration by Ciampolillo, A, Guastamacchia, E, Amati, L, Magrone, T, Munno, I, Jirillo, E, Triggiani, V, Fallacara, R, Tafaro, E

    Published in Current pharmaceutical design (01-01-2003)
    “…Hashimoto's thyroiditis, the most common form of autoimmune thyroid disease, is characterised by lymphocytic infiltration of the thyroid gland, gradual…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Vasopressin release induced by hypothension is blunted in patients with diabetic autonomic neuropathy by Iovino, M., Triggiani, V., Licchelli, B., Tafaro, E., Giagulli, V., Sabbà, C., Resta, F., Sciannimanico, S. V., Panza, R., Guastamacchia, E.

    Published in Immunopharmacology and immunotoxicology (01-03-2011)
    “…The response of arginin-vasopressin (AVP) to baroreceptor activation (tilt testing) was investigated in patients with diabetic autonomic neuropathy (DAN). The…”
    Get full text
    Journal Article
  18. 18
  19. 19

    In vitro secretion of interleukin-1 beta and interferon-gamma by peripheral blood lymphomononuclear cells in diabetic patients by Ciampolillo, A, Guastamacchia, E, Caragiulo, L, Lollino, G, De Robertis, O, Lattanzi, V, Giorgino, R

    Published in Diabetes research and clinical practice (01-08-1993)
    “…There is evidence that cytokines, in particular interleukin-1 beta (IL-1 beta) and interferon-gamma (IFN-gamma) might mediate beta cell destruction in type 1…”
    Get more information
    Journal Article
  20. 20

    Evolution of a prolactin-secreting pituitary microadenoma into a fatal carcinoma: a case report by Guastamacchia, E, Triggiani, V, Tafaro, E, De Tommasi, A, De Tommasi, C, Luzzi, S, Sabbà, C, Resta, F, Terreni, M R, Losa, M

    Published in Minerva endocrinologica (01-09-2007)
    “…Pituitary carcinomas are very rare tumors, nearly always presenting as widely invasive masses, although the hallmark of these lesions is the finding of distant…”
    Get more information
    Journal Article